North America Pacemakers Market Analysis and Forecasts to 2027 by Product Type, Technology and End User

North America Pacemakers Market to 2027- Regional Analysis and Forecasts By Product Type (Implantable Pacemakers, External Pacemakers) By Technology (Single Chambered, Dual Chambered, and Bi-Ventricular), By End User (Hospitals, Ambulatory Surgical Centers, and Others), and Country

  • Report Code : TIPRE00005754
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 137
Buy Now

The North America pacemakers market is expected to reach US$ 5,144.2 Mn in 2027 from US$ 2,607.1 Mn in 2018. The market is estimated to grow with a CAGR of 8.0% from 2019-2027.

Key factors that are driving the growth of the market are rising incidence of cardiovascular diseases, significant geriatric population present in the region that is susceptible to the risk of chronic heart diseases and presence of key players in the market and major technological advancements made by the North American players in the market.

Cardiovascular diseases represent a class of multiple diseases related to blood vessels and heart. According to the World Health Organization 2017, approximately 90% of cardiovascular diseases are preventable. The WHO also states that CVD is the leading cause of death in US and worldwide. In 2017, according to the World health organization, the increasing prevalence of cardiovascular diseases is the major cause of death all over the world. Cardiovascular disease is one of the leading causes of morbidity and mortality and is responsible for 30% of worldwide mortality, according to the World Health Organization. Moreover, according to the Centers of Disease Control and Prevention, Coronary heart disease (CHD) is the most common type of heart disease, killing over 370,000 people annually. Furthermore, according to the American Heart Association, in 2016, Coronary Heart Disease was the leading cause (43.2%) of deaths attributable to cardiovascular disease in the US, followed by stroke (16.9%), High Blood Pressure (9.8%), Heart Failure (9.3%), diseases of the arteries (3.0%), and other cardiovascular diseases (17.7%). Thus, such a high prevalence of cardiovascular diseases globally is anticipated to lead the market growth in the coming years.

The pacemakers market, based on product type, is segmented into implantable pacemakers and external pacemakers. In 2018, the implantable pacemakers segment held the largest share of the market, by product type. Moreover, the same segment of pacemakers market is also expected to witness growth in its demand at the fastest CAGR of 8.3% from 2019 to 2027. The spurring adoption of these devices relies majorly on the availability of reimbursement that results in reducing the economic burden on the patients in the developed economies that have a high prevalence of cardiovascular diseases. Moreover, the implantable pacemakers are highly penetrated in the market and thus are adopted as a first preference due to low risk, and other advantages offered by these devices.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

NORTH AMERICA PACEMAKERS– MARKET SEGMENTATION

By Product Type

  • Implantable Pacemakers
  • External Pacemakers

By Technology

  • Single Chambered
  • Dual Chambered
  • Bi-Ventricular

By End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Others

By Country

  • U.S
  • Canada
  • Mexico

Companies Mentioned

  • Medico S.p.A.
  • Vitatron
  • Abbott
  • Medtronic
  • OSCOR
  • LivaNova Plc
  • Abiomed
  • Boston Scientific Corporation
  • Biotronik
  • Lepu Medical
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product Type By Technology, By End User, and Country

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada

1. Introduction

1.1 Scope Of The Study

1.2 The Insight Partners Research Report Guidance

2. North America Pacemakers Market – Key Takeaways

3. North America Pacemakers Market – Market Landscape

3.1 Overview

3.2 Market Segmentation

3.2.1 North America Pacemakers Market – By Product Type

3.2.2 North America Pacemakers Market – By Technology

3.2.3 North America Pacemakers Market – By End User

3.2.4 North America Pacemakers Market – By Country

3.3 PEST Analysis

4. North America Pacemakers Market- Key Market Dynamics

4.1 Key Market Drivers

4.1.1 Rising Number of Patients Suffering with Cardiovascular Diseases

4.1.2 Introduction of Novel Pacemakers

4.2 Key Market Restraints

4.2.1 Product Recalls

4.3 Key Market Opportunities

4.3.1 Increasing Patient Compliance

4.4 Future Trends

4.4.1 Continuous Product Developments

4.5 Impact Analysis

5. Pacemakers Market – North America Analysis

5.1 North America Pacemakers Market Revenue Forecasts And Analysis

5.2 Market Positioning

5.3 Performance Of Key Players

6. Pacemakers Market – North America Regulatory Scenario

6.1 north america

6.1.1 US

6.1.2 Canada

6.1.3 Mexico

7. North America Pacemakers Market Analysis – By Product Type

7.1 Overview

7.2 North America Pacemakers Market, By Product Type, 2018 & 2027 (%)

7.3 North America Pacemakers Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

7.4 Implantable Pacemakers market

7.4.1 Overview

7.4.2 Implantable Pacemakers market Revenue and Forecast to 2027 (US$ Mn)

7.5 External Pacemakers Market

7.5.1 Overview

7.5.2 External Pacemakers Market Revenue and Forecast to 2027 (US$ Mn)

8. North America Pacemakers Market Analysis – By Technology

8.1 Overview

8.2 North America Pacemakers Market, By Technology, 2018 & 2027 (%)

8.3 North America Pacemakers Market Revenue And Forecasts To 2027, By Technology (US$ Mn)

8.4 Single Chambered Market

8.4.1 Overview

8.4.2 North America Single-Chambered Market Revenue and Forecasts to 2027 (US$ Mn)

8.5 Dual Chambered Market

8.5.1 Overview

8.5.2 North America Dual Chambered Market Revenue and Forecasts to 2027 (US$ Mn)

8.6 Bi-Ventricular Market

8.6.1 Overview

8.6.2 North America Bi-Ventricular Market Revenue and Forecasts to 2027 (US$ Mn)

9. North America Pacemakers Market Analysis – By End User

9.1 Overview

9.2 North America Pacemakers Market, By End User, 2018 & 2027 (%)

9.3 North America Pacemakers Market Revenue And Forecasts To 2027, By End User (US$ Mn)

9.4 Hospitals Market

9.4.1 Overview

9.4.2 North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

9.5 Ambulatory Surgical Centres Market

9.5.1 Overview

9.5.2 North America Ambulatory Surgical Centres Market Revenue and Forecasts to 2027 (US$ Mn)

9.6 Others Market

9.6.1 Overview

9.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

10. North America Pacemakers market

10.1.1 Overview

10.1.2 North America Pacemakers Market Revenue And Forecasts to 2027 (US$ Mn)

10.1.3 North America Pacemakers Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.1.4 North America Pacemakers Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.5 North America Pacemakers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.6 North America Pacemakers Market Revenue and Forecasts to 2027, By Country (%)

10.1.7 US Pacemakers Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8 US Pacemakers Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.1 US Pacemakers Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.1.8.2 US Pacemakers Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.8.3 US Pacemakers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.9 Canada Pacemakers Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.10 Canada Pacemakers Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.10.1 Canada Pacemakers Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.1.10.2 Canada Pacemakers Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.10.3 Canada Pacemakers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.11 Mexico Pacemakers Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.12 Mexico Pacemakers Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.12.1 Mexico Pacemakers Market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

10.1.12.2 Mexico Pacemakers Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.12.3 Mexico Pacemakers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11. Pacemakers Market – Industry Landscape

11.1 Overview

11.2 Comparative Company Analysis

11.3 Growth Strategies Done by the Companies in the Market, (%)

11.4 Organic Developments

11.4.1 Overview

11.5 Inorganic Developments

11.5.1 Overview

12. Pacemakers Market–Key Company Profiles

12.1 MEDICO S.p.A.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Financial Overview

12.1.4 Product Portfolio

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Vitatron Holding B.V.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Financial Overview

12.2.4 Product Portfolio

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Abbott

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Financial Information

12.3.4 Product Portfolio

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Medtronic

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Financial Information

12.4.4 Product Portfolio

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 OSCOR Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Financial Information

12.5.4 Product Portfolio

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 LivaNova PLC

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Financial Overview

12.6.4 Product Portfolio

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 LEpu Medical

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Financial Overview

12.7.4 Product Portfolio

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Boston Scientific Corporation

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Financial Overview

12.8.4 Product Portfolio

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 BIOTRONIK

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Financial Overview

12.9.4 Product Portfolio

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Pacetronix

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Financial Overview

12.10.4 Product Portfolio

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary Of Terms

13.3 Methodology

13.3.1 Coverage

13.3.2 Secondary Research

13.3.3 Primary Research

LIST OF TABLES

Table 1. North America Pacemakers Market Revenue And Forecasts To 2027, By Product Type (US$ Mn)

Table 2. North America Pacemakers Market Revenue And Forecasts To 2027, By Technology (US$ Mn)

Table 3. North America Pacemakers Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 4. North America Pacemakers market Revenue And Forecasts to 2027, By Product type (US$ Mn)

Table 5. North America Pacemakers market Revenue And Forecasts to 2027, By technology (US$ Mn)

Table 6. North America Pacemakers market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 7. US Pacemakers market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

Table 8. US Pacemakers market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 9. US Pacemakers market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 10. Canada Pacemakers market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

Table 11. Canada Pacemakers market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 12. Canada Pacemakers market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 13. Mexico Pacemakers market Revenue And Forecasts to 2027, By Product Type (US$ Mn)

Table 14. Mexico Pacemakers market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 15. Mexico Pacemakers market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 16. Organic Developments Done By Companies

Table 17. Inorganic developments done by Companies

Table 18. Glossary Of Terms, Pacemakers Market

LIST OF FIGURES

Figure 1. US Pacemakers Market, Revenue (US$ Mn), By Country 2018 & 2027

Figure 2. North America Pacemakers Market By Product Type, Market Share (%), 2018

Figure 3. North America Pacemakers Market By Technology, Market Share (%), 2018

Figure 4. North America Pacemakers Market By End User, Market Share (%), 2018

Figure 5. Pacemakers Market Segmentation

Figure 6. North America PEST Analysis

Figure 7. Pacemakers Market Impact Analysis Of Drivers & Restraints

Figure 8. North America Pacemakers Market – Revenue Forecasts And Analysis – 2018- 2027

Figure 9. North America Pacemakers Market, By Product Type, 2018 & 2027 (%)

Figure 10. Implantable Pacemakers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 11. External Pacemakers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 12. North America Pacemakers Market By Technology, 2017 & 2025 (%)

Figure 13. North America Single Chambered Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 14. North America Dual Chambered Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 15. North America Bi-Ventricular Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 16. North America Pacemakers Market By End User, 2018 & 2027 (%)

Figure 17. North America Hospitals Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 18. North America Ambulatory Surgical Centers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19. North America Others Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20. North America Pacemakers market revenue Overview, by Country (2017) (us $ mn)

Figure 21. North America Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22. North America Pacemakers market Revenue And Forecasts to 2027, By Country (%)

Figure 23. US Pacemakers market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24. Canada Pacemakers market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25. Mexico Pacemakers market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26. Comparative Company Analysis

Figure 27. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies

 

  1. Medico S.p.A.
  2. Vitatron
  3. Abbott
  4. Medtronic
  5. OSCOR
  6. LivaNova Plc
  7. Abiomed
  8. Boston Scientific Corporation
  9. Biotronik
  10. Lepu Medical

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to North America Pacemakers Market